<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39421622</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-861X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in nutrition</Title><ISOAbbreviation>Front Nutr</ISOAbbreviation></Journal><ArticleTitle>Effect of vitamin C supplementation on outcomes in patients with COVID-19: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1465670</StartPage><MedlinePgn>1465670</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1465670</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fnut.2024.1465670</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Since the emergence of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), millions of lives have been lost, posing formidable challenges to healthcare systems worldwide. Our study aims to conduct a meta-analysis to evaluate the efficacy of vitamin C supplementation in reducing in-hospital mortality rates and shortening the length of ICU or hospital stays among patients diagnosed with COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A comprehensive systematic review and meta-analysis was conducted, sourcing data from PubMed, Embase, Scopus, and the Cochrane Central Register of Controlled Trials. Our analysis focused on randomized clinical trials comparing the efficacy of vitamin C supplementation with standard care in adult COVID-19 patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Through meticulous examination of 11 clinical trials, our meta-analysis found that vitamin C supplementation did not reduce in-hospital mortality rates in COVID-19 patients compared to those receiving standard care (Risk Ratio [RR] = 0.85; 95% Confidence Interval [CI]: 0.62-1.17; <i>p</i> = 0.31). Similarly, the analysis indicated no significant difference in the length of ICU stays between both cohorts. Additionally, the occurrence of other adverse events was found to be similar across both groups treated with vitamin C supplementation and standard care (all <i>p</i> &gt; 0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Vitamin C supplementation did not reduce in-hospital mortality or ICU stay durations in patients with COVID-19. The interpretation of these findings is limited by the small number of available studies and participants, which affects the strength of the conclusions.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="UNASSIGNED">Identifier CRD42024497474.</AbstractText><CopyrightInformation>Copyright © 2024 Xu, Wang, Wan, Tan, Liu, Chen, Zheng, Yu, Fan, Jorge Luis and Zhang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Xu</LastName><ForeName>Wenhao</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Evidence-based Medicine, Affiliated Hospital of Chengdu University, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Affiliated Hospital of Chengdu University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wan</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Evidence-based Medicine, Affiliated Hospital of Chengdu University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Yaheng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Affiliated Hospital of Chengdu University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yuyang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Affiliated Hospital of Chengdu University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qiwen</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Affiliated Hospital of Chengdu University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Yuxin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Affiliated Hospital of Chengdu University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Xueying</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Affiliated Hospital of Chengdu University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Sitong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Affiliated Hospital of Chengdu University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jorge Luis</LastName><ForeName>Cuyubamba Dominguez</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center for Evidence-based Medicine, Affiliated Hospital of Chengdu University, Chengdu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Nutr</MedlineTA><NlmUniqueID>101642264</NlmUniqueID><ISSNLinking>2296-861X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">hospital mortality</Keyword><Keyword MajorTopicYN="N">length of stay</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">vitamin C</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>10</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>4</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39421622</ArticleId><ArticleId IdType="pmc">PMC11484096</ArticleId><ArticleId IdType="doi">10.3389/fnut.2024.1465670</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yang B, Xu LY, Li LY, Qiao DF, Du SH, Yue X, et al. . Pathological changes and cause of death associated with the global novel coronavirus disease (COVID-19). Fa Yi Xue Za Zhi. (2023) 39:586–95. doi: 10.12116/j.issn.1004-5619.2023.430703, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.12116/j.issn.1004-5619.2023.430703</ArticleId><ArticleId IdType="pubmed">38228478</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezzikouri S, Nourlil J, Benjelloun S, Kohara M, Tsukiyama-Kohara K. Coronavirus disease 2019-historical context, virology, pathogenesis, immunotherapy, and vaccine development. Hum Vaccin Immunother. (2020) 16:2992–3000. doi: 10.1080/21645515.2020.1787068, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2020.1787068</ArticleId><ArticleId IdType="pmc">PMC8641599</ArticleId><ArticleId IdType="pubmed">32755425</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Obaidi ZMJ, Hussain YA, Ali AA, Al-Rekabi MD. The influence of vitamin-C intake on blood glucose measurements in COVID-19 pandemic. J Infect Dev Ctries. (2021) 15:209–13. doi: 10.3855/jidc.13960, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.13960</ArticleId><ArticleId IdType="pubmed">33690202</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C, Kraft K. Feasibility of vitamin C in the treatment of post viral fatigue with focus on long COVID, based on a systematic review of IV vitamin C on fatigue. Nutrients. (2021) 13:1154. doi: 10.3390/nu13041154</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13041154</ArticleId><ArticleId IdType="pmc">PMC8066596</ArticleId><ArticleId IdType="pubmed">33807280</ArticleId></ArticleIdList></Reference><Reference><Citation>Olczak-Pruc M, Swieczkowski D, Ladny JR, Pruc M, Juarez-Vela R, Rafique Z, et al. . Vitamin C supplementation for the treatment of COVID-19: a systematic review and Meta-analysis. Nutrients. (2022) 14:4217. doi: 10.3390/nu14194217</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14194217</ArticleId><ArticleId IdType="pmc">PMC9570769</ArticleId><ArticleId IdType="pubmed">36235869</ArticleId></ArticleIdList></Reference><Reference><Citation>Adhikari NKJ, Hashmi M, Vijayaraghavan BKT, Haniffa R, Beane A, Webb SA, et al. . Intravenous vitamin C for patients hospitalized with COVID-19: two harmonized randomized clinical trials. JAMA. (2023) 330:1745–59. doi: 10.1001/jama.2023.21407, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.21407</ArticleId><ArticleId IdType="pmc">PMC10600726</ArticleId><ArticleId IdType="pubmed">37877585</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. (2021) 372:n71. doi: 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. . The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. (2015) 162:777–84. doi: 10.7326/M14-2385, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M14-2385</ArticleId><ArticleId IdType="pubmed">26030634</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. . RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. (2019) 366:l4898. doi: 10.1136/bmj.l4898</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Warn DE, Thompson SG, Spiegelhalter DJ. Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Stat Med. (2002) 21:1601–23. doi: 10.1002/sim.1189, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1189</ArticleId><ArticleId IdType="pubmed">12111922</ArticleId></ArticleIdList></Reference><Reference><Citation>Beigmohammadi MT, Bitarafan S, Hoseindokht A, Abdollahi A, Amoozadeh L, Soltani D. The effect of supplementation with vitamins a, B, C, D, and E on disease severity and inflammatory responses in patients with COVID-19: a randomized clinical trial. Trials. (2021) 22:802. doi: 10.1186/s13063-021-05795-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-021-05795-4</ArticleId><ArticleId IdType="pmc">PMC8590866</ArticleId><ArticleId IdType="pubmed">34776002</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppock D, Violet PC, Vasquez G, Belden K, Foster M, Mullin B, et al. . Pharmacologic ascorbic acid as early therapy for hospitalized patients with COVID-19: a randomized clinical trial. Life (Basel, Switzerland). (2022) 12:453. doi: 10.3390/life12030453</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12030453</ArticleId><ArticleId IdType="pmc">PMC8954118</ArticleId><ArticleId IdType="pubmed">35330204</ArticleId></ArticleIdList></Reference><Reference><Citation>Darban M, Malek F, Memarian M, Gohari A, Kiani A, Emadi A, et al. . Efficacy of high dose vitamin C, melatonin and zinc in Iranian patients with acute respiratory syndrome due to coronavirus infection: a pilot randomized trial. J Cell Mol Anesth. (2021) 6:164–7. doi: 10.22037/jcma.v6i2.32182</Citation><ArticleIdList><ArticleId IdType="doi">10.22037/jcma.v6i2.32182</ArticleId></ArticleIdList></Reference><Reference><Citation>JamaliMoghadamSiahkali S, Zarezade B, Koolaji S, SeyedAlinaghi SA, Zendehdel A, Tabarestani M, et al. . Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial. Eur J Med Res. (2021) 26:20. doi: 10.1186/s40001-021-00490-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-021-00490-1</ArticleId><ArticleId IdType="pmc">PMC7877333</ArticleId><ArticleId IdType="pubmed">33573699</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari P, Dembra S, Dembra P, Bhawna F, Gul A, Ali B, et al. . The role of vitamin C as adjuvant therapy in COVID-19. Cureus. (2020) 12:e11779. doi: 10.7759/cureus.11779</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.11779</ArticleId><ArticleId IdType="pmc">PMC7779177</ArticleId><ArticleId IdType="pubmed">33409026</ArticleId></ArticleIdList></Reference><Reference><Citation>Majidi N, Rabbani F, Gholami S, Gholamalizadeh M, BourBour F, Rastgoo S, et al. . The effect of vitamin C on pathological parameters and survival duration of critically ill coronavirus disease 2019 patients: a randomized clinical trial. Front Immunol. (2021) 12:717816. doi: 10.3389/fimmu.2021.717816</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.717816</ArticleId><ArticleId IdType="pmc">PMC8714637</ArticleId><ArticleId IdType="pubmed">34975830</ArticleId></ArticleIdList></Reference><Reference><Citation>Tehrani S, Yadegarynia D, Abrishami A, Moradi H, Gharaei B, Rauofi M, et al. . An investigation into the effects of intravenous vitamin C on pulmonary CT findings and clinical outcomes of patients with COVID 19 pneumonia a randomized clinical trial. Urol J. (2022) 19:460–5. doi: 10.22037/uj.v18i.6863, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.22037/uj.v18i.6863</ArticleId><ArticleId IdType="pubmed">34746999</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas S, Patel D, Bittel B, Wolski K, Wang Q, Kumar A, et al. . Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2 infection: the COVID a to Z randomized clinical trial. JAMA Netw Open. (2021) 4:e210369. doi: 10.1001/jamanetworkopen.2021.0369, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0369</ArticleId><ArticleId IdType="pmc">PMC7881357</ArticleId><ArticleId IdType="pubmed">33576820</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Rao X, Li Y, Zhu Y, Liu F, Guo G, et al. . Pilot trial of high-dose vitamin C in critically ill COVID-19 patients. Ann Intensive Care. (2021) 11:5. doi: 10.1186/s13613-020-00792-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00792-3</ArticleId><ArticleId IdType="pmc">PMC7794643</ArticleId><ArticleId IdType="pubmed">33420963</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakamifard A, Soltani R, Maghsoudi A, Rismanbaf A, Aalinezhad M, Tarrahi MJ, et al. . The effect of vitamin E and vitamin C in patients with COVID-19 pneumonia; a randomized controlled clinical trial. Immunopathol Persa. (2022) 8:e8. doi: 10.34172/ipp.2022.08</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/ipp.2022.08</ArticleId></ArticleIdList></Reference><Reference><Citation>Kow CS, Hasan SS, Ramachandram DS. The effect of vitamin C on the risk of mortality in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. Inflammopharmacology. (2023) 31:3357–62. doi: 10.1007/s10787-023-01200-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-023-01200-5</ArticleId><ArticleId IdType="pmc">PMC10111321</ArticleId><ArticleId IdType="pubmed">37071316</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>